Your browser doesn't support javascript.
loading
Synergistic activity of combinations of recombinant human alpha interferon and acyclovir, administered concomitantly and in sequence, against a lethal herpes simplex virus type 1 infection in mice.
Antimicrob Agents Chemother ; 28(1): 1-4, 1985 Jul.
Article em En | MEDLINE | ID: mdl-4037769
The nucleoside analog acyclovir [9-(2-hydroxyethoxymethyl)guanine] and the hybrid recombinant human alpha interferon (rHuIFN-alpha A/D) were evaluated in weanling mice for their efficacy alone and in combination against a lethal systemic infection with herpes simplex virus type 1. Simultaneous parenteral treatment with combinations of both agents at various doses resulted in a higher percentage of survival than when either agent was administered alone, with a synergistic interaction demonstrated at certain dose combinations. Sequential administration of parenteral rHuIFN-alpha A/D and oral acyclovir, administered by gavage or supplied ad libitum in drinking water, resulted in a synergistic interaction at all dose combinations tested. These results suggest that combinations of interferon and acyclovir may be useful in treating primary herpes simplex virus infections in humans.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aciclovir / Interferon Tipo I / Herpes Simples Limite: Animals Idioma: En Ano de publicação: 1985 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aciclovir / Interferon Tipo I / Herpes Simples Limite: Animals Idioma: En Ano de publicação: 1985 Tipo de documento: Article